Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-16-080073
Filing Date
2016-02-09
Accepted
2016-02-09 17:19:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G v430951_sc13g.htm SC 13G 53329
  Complete submission text file 0001144204-16-080073.txt   54838
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43329 | Film No.: 161401063
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 WEST ADAMS STREET CHICAGO IL 60606
Business Address 222 WEST ADAMS STREET CHICAGO IL 60606 312-236-1600
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by) CIK: 0001644956 (see all company filings)

EIN.: 472614791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G